Bibliography

    1. Metabolice Surgery: Weight Loss, Diabetes, and Beyond MananPareekMD, PhDabPhilip R.SchauerMDcLee M.KaplanMD, PhDdLawrence A.LeiterMDeFrancescoRubinoMDfDeepak L. BhattMD, MPH
    2. Metabolic (Bariatric and Nonbariatric) Surgery for Type 2 Diabetes: A Personal Perspective Review, Henry Buchwald1,2 and Jane N. Buchwald
    3. Weiner, RA, et al. (2010). Indications and principles of metabolic surgery. US National Library of Medicine. 81 (4) pp. 379-394. Accessed from: https://www.ncbi.nlm.nih.gov/pubmed/20361370
    4. The Effectiveness and Risks of Bariatric Surgery: An Updated Systematic Review and Meta-analysis, 2003-2012 Accessed from: https://jamanetwork.com/journals/jamasurgery/fullarticle/1790378
    5. Sjöström. L., et al. (2007). Effects of bariatric surgery on mortality in Swedish obese subjects. New England Journal of Medicine. 357 pp. 741-752 Accessed October 2013 from http://www.nejm.org/doi/pdf/10.1056/NEJMoa066254
    6. Adams, TD, et al. (2007). Long-term mortality after gastric bypass surgery. New England Journal of Medicine. 357 pp. 753-761. Accessed from: https://www.nejm.org/doi/full/10.1056/NEJMoa066603 
    7. Buchwald, H., et al. (2009). Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. American Journal of Medicine. 122 (3) pp. 205- 206. Accessed from http://www.ncbi.nlm.nih.gov/pubmed/19272486
    8. The Effectiveness and Risks of Bariatric Surgery: An Updated Systematic Review and Meta-analysis, 2003-2012 Accessed from: https://jamanetwork.com/journals/jamasurgery/fullarticle/1790378
    9. Wittgrove, AC, et al. (2000). Laparoscopic gastric bypass, roux-en-y: 500 patients: technique and results, with 3-60 month follow-up. Obesity Surgery. 10 (3) pp. 233-239. Accessed from http://www.lapbypass.com/pdf/LapGBP_500Patients.pdf
    10. Buchwald, H., et al. (2004). Bariatric surgery: a systematic review and meta-analysis. Journal of the American Medical Association. 292 (12) pp. 1724-1737 Accessed from http://jama.ama-assn.org/content/292/14/1724.full
    11. Agency for Healthcare Research and Quality (AHRQ). (2007). Statistical Brief #23. Bariatric Surgery Utilization and Outcomes in 1998 and 2004. Accessed October 2013 from http://www.hcup-us.ahrq.gov/reports/statbriefs/sb23.jsp
    12. Flum, DR, et al. (2009). Perioperative safety in the longitudinal assessment of bariatric surgery. New England Journal of Medicine. 361 pp. 445-454. Accessed October 2013 from http://content.nejm.org/cgi/content/full/361/5/445 
    13. Sjöström. L., et al. (2007). Effects of bariatric surgery on mortality in Swedish obese subjects. New England Journal of Medicine. 357 pp. 741-752. Accessed from: https://www.nejm.org/doi/pdf/10.1056/NEJMoa066254
    14. Telem, DA, et al. Long-term mortality rates (> 8-year) improve as compared to the general and obese population following bariatric surgery. Surg Endosc. 2015 Mar; 29 (3): 529-36. DOI: 10.1007 / s00464-014-3714-4. Epub
    15. The Effectiveness and Risks of Bariatric Surgery: An Updated Systematic Review and Meta-analysis, 2003-2012 Accessed from: https://jamanetwork.com/journals/jamasurgery/fullarticle/1790378
    16. Christou, NV, et al. (2008). Bariatric surgery reduces cancer risk in morbidly obese patients. Surgery for Obesity and Related Diseases. 4 (6) pp. 691-95. Accessed from http://www.ncbi.nlm.nih.gov/pubmed/19026373 
    17. Steele CB, Thomas CC, Henley SJ, et al. Vital Signs: Trends in Incidence of Cancers Associated with Overweight and Obesity - United States, 2005–2014. MMWR Morb Mortal Wkly Rep 2017; 66: 1052–1058. DOI: http://dx.doi.org/10.15585/mmwr.mm6639e1
    18. Adams, TD, et al. (2007). Long-term mortality after gastric bypass surgery. New England Journal of Medicine. 357 pp. 753-761 Accessed from http://www.nejm.org/doi/full/10.1056/NEJMoa066603
    19. https://onlinelibrary.wiley.com/doi/full/10.1111/joim.12012 
    20. Sampalis JS, et al. (2004). Impact of weight reduction surgery on health care costs in morbidly obese patients. Obesity Surgery. Accessed from: https://www.ncbi.nlm.nih.gov/pubmed/10605908 
    21. World Health Organization. Obesity and Overweight Fact Sheet. How Does Excess Body Fat Impact Health.http: //www.who.int/dietphysicalactivity/media/en/asfs obesity.pdf
    22. Schauer, PR, et al. (2003). Effect of Laparoscopic Roux-En Y Gastric Bypass on T2DM Section: Discussion. Annals of Surgery.doi: 10.1097 /01.sla.0000089851.41115.1b
    23. Schauer, PR, et al. (2017). Bariatric Surgery versus Intensive Medical Therapy for Diabetes 5-Year Outcomes. NEJM DOI: 10.1056 / NEJMoal600869
    24. Mingrone, G., et al. (2015). Bariatric-metabolic surgery versUS conventional medical treatment in obese patients with T2D: 5 year follow-up of an openlabel, single-center, randomized controlled trial. The Lancet. 386,999, P964-973. DOt https://doi.org/10.1016/S0140-6736(15)00075-6
    25. ADA (2016). Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: Diabetes Care. 39 (6): 861-877.https: //doi.ora/10.2337/dc16-0236
    26. American Society for Metabolic and Bariatric Surgery (ASMBS). (2018). ASMBS updated position statement on bariatric surgery in class I obesity (BMI30-35 kg / m2). Article in Press: June 9, 2018. DOE https://doi.org/10.1016/isoard.2018.05.025
    27. Buchwald, H., et al. (2009). Weight and Type 2 Diabetes after Bariatric Surgery: Systematic Review and Meta-analysis. Am J Med. Https://doi.org/10.1016/iamimed.2008.09.041
    28. Schauer, PR, et al. (2017). Bariatric Surgery versus Intensive Medical Therapy for Diabetes-5-Year Outcomes. NEJM DOI: 10.1056 / NEJMoal600869
    29. Schauer, PR, et al. (2012). Bariatric Surgery vs. Intensive Medical Therapy in Obese Patients with Diabetes. NEJM; 366: 1567-1576 DOE 10.1056 / NEJMoa1200225
    30. Schauer, PR, et al. (2014). Bariatric Surgery versus Intensive Medical Therapy for Diabetes-3-Year Outcomes. NEJM 370: 2002-2013. DO: 10.1056 / NEJMoa1401329
    31. Brethauer, SA, et. to the. (2013). Can Diabetes Be Surgically Cured? Annals of Surgery. doi: 10.1097 / SLA.0b013e3182a5034b
    32. Sjostrom L., et al. (2014). Association of bariatric surgery with long-term remission of T2D and with microvascular and macrovascular complications. JAMA. doi: 10.1001 / jama.2014.5988
    33. Adams, TD, et al. (2007). Long-term mortality after gastric bypass surgery. New Engl J Med. 357: 753-761 DOI: 10.1056 / NEJMoa066603
    34. Eliasson, B., et al. (2015). Cardiovascular disease and mortality in patients with type 2 diabetes after bariatric surgery in Sweden: a nationwide, matched, observational cohort study. The Lancet Diabetes & Endocrinology. 3:11, P847-854. DOkhttps: //doi.org/10.1016/S2213-8587 (15) 00334-4
    35. Adams TD, et al. (2017). Weight and metabolic outcomes 12 years after gastric bypass. N Engl J Med. 377: 1143-1155. doi: 10.1056 / NEJMoa1700459
    36. Billeter et al. (2018). Meta-analysis of metabolic surgery versus medical treatment for microvascular complications in patients with T2DM. BrJSurg, doi: 10.1002 / bis.10724.
    37. O'Brien PE, et. to the. (2018). Microvascular Outcomes in Patients With Diabetes After Bariatric Surgery Versus Usual Care: Annals of Internal Medicine. DOI: 10.7326 / M1Z- 2383
    38. Maggard-Gibbons M., et. to the. (2013). Bariatric Surgery for Weight Loss and Glycemic Control in Non Obese Adults With Diabetes. JAMA. doi: 10.1001 / iama.2013.4851
    39. Lee, WJ et al. (2011). Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial. Arch Surg. 146 (2): 143-8. doi: 10.1001 / archsura.2010.326.
    40. Chih-Cheng H., et al. (2015). Effect of Bariatric Surgery vs Medical Treatment on T2D in Patients With BMI Lower Than 35. JAMA Surg. doi: 10.1001 /jamasura.2015.2602
    41. World Health Organization. Obesity and Overweight Fact Sheet. http://www.who.int/dietphysicalactivity/media/en/gsfs_obesity.pdf Accessed August 30, 2018.
    42. Verma S, Hussain ME. Obesity and diabetes: An update. Diabetes Metab Syndr. 2017; 11 (1): 73–79. Epub 2016 Jun 17.
    43. Mason, EE, Ito C. Gastric bypass in obesity. Surg Clin North Am. 1967; 47: 1345-1351.
    44. Deitel M, Melissas J. The origin of the word "bari". Obes Surg. 2005; 15 (7): 1005-1008.
    45. Gadde KM, Martin CK, et al. Obesity: pathophysiology and management. J Am Coll Cardiol. 2018; 71 (1): 69-84.
    46. Sims EA, Danforth E Jr, Horton ES, Bray GA, Glennon JA, Salans LB. Endocrine and metabolic effects of experimental obesity in man. Recent Prog Horm Res. 1973; 29: 457-496.
    47. Mechanick JI, Hurley D, Garvey WT. Adiposity-based chronic disease as a new diagnostic term: The American Association of Clinical Endocrinologists and American College of Endocrinology position statement. Endocr Pract. 2017; 23 (3): 372-378.
    48. International Diabetes Federation. IDF Diabetes Atlas, 8th edn. Brussels, Belgium: International Diabetes Federation, 2017
    49. Schauer D, et al. Bariatric surgery and the risk of cancer in a large multisite cohort. Ann Surg. 2017 Sep 21. [Epub ahead of print.
    50. Field AE, Coakley EH, Must A, et al. Impact of overweight on the risk of developing common chronic diseases during a 10-year period. Arch Intern Med. 2001; 161: 1581-1586.
    51. Adams KF, Schatzkin A, Harris TB, et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old, N Engl J Med. 2006; 355: 763-778.
    52. Adams TD, Arterburn DE, Nathan DM, Eckel RH. Clinical outcomes of metabolic surgery: microvascular and macrovascular complications. Diabetes Care. 2016; 39 (6): 912-923.
    53. Adams T, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007; 357: 753-761.
    54. Kheniser KG, Kashyap SR. Diabetes management before, during, and after bariatric and metabolic surgery. J Diabetes Complications. 2018; 32 (9): 870-875.
    55. Mingrone G, Castagneto-Gissey L. Mechanisms of early improvement / resolution of type 2 diabetes after bariatric surgery. Diabetes Metab. 2009; 35 (6 Pt 2): 518-523.
    56. Rubino F, Nathan DM, Eckel RH, et al. 2nd Diabetes Surgery Summit. Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations. Diabetes Care. 2016; 39: 861-877.
    57. Dixon JB, O'Brien PE, Playfair J, Chapman L, Schachter LM. Skinner S. et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008; 299: 316-323.
    58. Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012; 366: 1577-1585.
    59. Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012; 366: 1567-1576.
    60. Ikramuddin S, Korner J, Lee WJ, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the diabetes surgery study randomized clinical trial. JAMA. 2013; 309: 2240-2249.
    61. Abdeen G, le Roux CW. Mechanism underlying the weight loss and complications of Roux-en-Y gastric bypass. Review Obes Surg. 2016; 26: 410-421.
    62. Halperin F, Ding SA, Simonson DC, et al. Roux-en-Y gastric bypass surgery or lifestyle with intensive medical management in patients with type 2 diabetes: feasibility and 1-year results of a randomized clinical trial. JAMA Surg. 2014; 149: 716-726.
    63. Parikh M, Chung M, Sheth S, et al. Randomized pilot trial of bariatric surgery versus intensive medical weight management on diabetes
    64. remission in type 2 diabetic patients who do NOT meet NIH criteria for surgery and the role of soluble RAGE as a novel biomarker of success. Ann Surg. 2014; 260: 617-622. discussion 622-624.
    65. Schauer PR, Bhatt DL, Kirwan JP, et al .; STAMPEDE Investigators. Bariatric surgery versus intensive medical therapy for diabetes-3-year outcomes. N Engl J Med, 2014; 370: 2002-2013.
    66. Wentworth JM, Playfair J, Laurie C, et al. Multidisciplinary diabetes care with and without bariatric surgery in overweight people: a randomized controlled trial. Lancet Diabetes Endocrinol. 2014; 2: 545-552.
    67. Courcoulas AP, Belle SH, Neiberg RH, et al. Three-year outcomes of bariatric surgery vs lifestyle intervention for type 2 diabetes mellitus treatment: a randomized clinical trial. JAMA Surg. 2015; 150: 931-940.
    68. Ding SA, Simonson DC, Wewalka M, et al. Adjustable gastric band surgery or medical management in patients with type 2 diabetes: a randomized clinical trial. J Clin Endocrinol Metab. 2015; 100: 2546-2556.
    69. Cummings DE, Arterburn DE, Westbrook EO, et al. Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomized controlled trial. Diabetology. 2016; 59: 945-953.
    70. Schauer PR, Mingrone G, Ikramuddin S, Wolfe B. Clinical outcomes of metabolic surgery: efficacy of glycemic control, weight loss, and remission of diabetes. Diabetes Care. 2016; 39 (6): 902-911
    71. Benjamin et al. Heart Disease and Stroke Statistics— 2018 Update: a report from the American Heart Association. Circulation. 2018; 137: e67 – e492. DOI: 10.1161 / CIR.0000000000000558 
    72. Benjamin et al. Heart Disease and Stroke Statistics— 2018 Update: a report from the American Heart Association. Circulation. 2018; 137: e67 – e492. DOI: 10.1161 / CIR.0000000000000558
    73. Benotti et al. Gastric Bypass Surgery Produces a Durable Reduction in Cardiovascular Disease Risk Factors and Reduces the Long-Term Risks of Congestive Heart Failure. Journal of the American Heart Association. May 2017 https://www.ahajournals.org/doi/10.1161/JAHA.116.005126
    74. Sundström et al. Weight Loss and Heart Failure: A Nationwide Study of Gastric Bypass Surgery Versus Intensive Lifestyle Treatment. Circulation. 2017 Apr 25; 135 (17): 1577-1585. doi: 10.1161 / CIRCULATIONAHA.116.025629. Epub 2017 Mar 3. https://www.ahajournals.org/doi/abs/10.1161/circulationaha.116.025629
    75. Adams et al. Long-Term Mortality after Gastric Bypass Surgery. N Engl J Med 2007; 357: 753-761 DOI: 10.1056 / NEJMoa066603 https://www.nejm.org/doi/full/10.1056/NEJMoa066603  https://www.cdc.gov/heartdisease/other_conditions.htm
    76. https://www.cdc.gov/dhdsp/data_statistics/fact_sheets/fs_heart_failure.htm
    77. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3250069/
    78. Khan SS, Ning H, Wilkins JT, et al. Association of Body Mass Index With Lifetime Risk of Cardiovascular Disease and Compression of Morbidity. JAMA Cardiol. 2018; 3 (4): 280–287. doi: 10.1001 / jamacardio.2018.0022
    79. Khan SS, Ning H, Wilkins JT, et al. Association of Body Mass Index With Lifetime Risk of Cardiovascular Disease and Compression of Morbidity. JAMA Cardiol. 2018; 3 (4): 280–287. doi: 10.1001 / jamacardio.2018.0022
    80. https://www.heart.org/idc/groups/heart-public/@wcm/@adv/documents/downloadable/ucm_305059.pdf
    81. Landsberg et al. Obesity-Related Hypertension: Pathogenesis, Cardiovascular Risk, and Treatment. A Position Paper of The Obesity Society and the American Society of Hypertension. https://onlinelibrary.wiley.com/doi/epdf/10.1111/jch.12049
    82. Abdullah A, Peeters A, de Courten M, Stoelwinder J. The magnitude of association between overweight and obesity and the risk of diabetes: A meta-analysis of prospective cohort studies. Diabetes Res Clin Pract. 2010 Sep; 89 (3): 309–19 https://www.ncbi.nlm.nih.gov/pubmed/20493574
    83. American Diabetes Association. Living with Diabetes. Complications. Heart Disease http://www.diabetes.org/living-with-diabetes/complications/heart-disease/
    84. American Diabetes Association. Living with Diabetes. Complications. Heart Disease http://www.diabetes.org/living-with-diabetes/complications/heart-disease/
    85. Adams et al. Long-Term Mortality after Gastric Bypass Surgery. N Engl J Med 2007; 357: 753-761 DOI: 10.1056 / NEJMoa066603 https://www.nejm.org/doi/full/10.1056/NEJMoa066603
    86. Sundström et al. Weight Loss and Heart Failure: A Nationwide Study of Gastric Bypass Surgery Versus Intensive Lifestyle Treatment.Circulation. 2017 Apr 25; 135 (17): 1577-1585. doi: 10.1161 / CIRCULATIONAHA.116.025629. Epub 2017 Mar 3. https://www.ahajournals.org/doi/abs/10.1161/circulationaha.116.025629
    87. Benotti et al. Gastric Bypass Surgery Produces a Durable Reduction in Cardiovascular Disease Risk Factors and Reduces the Long-Term Risks of Congestive Heart Failure. Journal of the American Heart Association. May 2017 https://www.ahajournals.org/doi/10.1161/JAHA.116.005126
    88. Fisher DP, Johnson E, Haneuse S, et al. Association Between Bariatric Surgery and Macrovascular Disease Outcomes in Patients With Type 2 Diabetes and Severe Obesity. JAMA. 2018; 320 (15): 1570–1582. doi: 10.1001 / jama.2018.14619 http://circ.ahajournals.org/content/early/2017/11/10/CIRCULATIONAHA.117.032130 
    89. Targeting Islets: Metabolic Surgery Is More than a Bariatric Surgery, Xi ChenJingjing zhang & Zhiguang Zhou Obesity Surgery  (2019)
    90. Obesity Management for the Treatment of Type 2 Diabetes: Standards of Medical Care in Diabetes — 2019 American Diabetes Association
    91. American Society for Metabolic and Bariatric Surgery (ASMBS)
Menu
en_USEnglish